Advanced Accelerator Application SA (NASDAQ:AAAP) shares were down 3.1% on Thursday . The stock traded as low as $33.00 and last traded at $33.33, with a volume of 164,449 shares. The stock had previously closed at $34.40.

Several research analysts have recently weighed in on AAAP shares. Canaccord Genuity restated a “buy” rating on shares of Advanced Accelerator Application SA in a research note on Tuesday, May 31st. Zacks Investment Research upgraded Advanced Accelerator Application SA from a “hold” rating to a “buy” rating and set a $40.00 price target for the company in a research note on Thursday, April 28th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $35.67.

The company has a 50 day moving average of $31.54 and a 200 day moving average of $31.83. The stock’s market capitalization is $1.23 billion.

Advanced Accelerator Applications SA is a radiopharmaceutical company that develops, produces and sells molecular nuclear medicine (MNM), diagnostic and therapeutic products. The Company’s lead therapeutic candidate, Lutathera, is being developed for the treatment of midgut neuroendocrine tumors (NETs).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.